Lyell ImmunopharmaLYEL
那斯達克 · USD
24.29
+0.28
(+1.17%)
盤中 04/20 09:33 (UTC+8)
04/20 09:33 (UTC+8)
Lyell ImmunopharmaLYEL
24.29
+0.28
(+1.17%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- -7.41
- -48.00
- -76.92
- 333.33
- 161.54
- -67.65
- -36.36
- 14.29
- 87.50
- -60.00
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 6 | 15 | 8 | 7 | 11 | 34 | 13 | 3 | 13 | 25 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 6 | 15 | 8 | 7 | 11 | 34 | 13 | 3 | 13 | 25 |
營業費用 | 127,650 | 37,268 | 47,148 | 57,374 | 201,158 | 50,539 | 51,541 | 55,578 | 59,521 | 59,064 |
研發費用 | 52,199 | 28,172 | 34,857 | 43,447 | 48,668 | 39,500 | 40,261 | 43,174 | 46,995 | 43,849 |
推銷及管理費用 | 9,119 | 9,096 | 10,848 | 13,927 | 14,009 | 11,039 | 11,280 | 12,404 | 12,526 | 15,215 |
非經常性項目費用 | 66,332 | - | 1,443 | - | 138,481 | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -127,644 | -37,253 | -47,140 | -57,367 | -201,147 | -50,505 | -51,528 | -55,575 | -59,508 | -59,039 |
其他收入及費用 | -13,079 | -1,593 | 4,456 | 5,172 | 9,212 | 5,922 | 5,719 | -5,092 | 6,578 | 8,186 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -140,723 | -38,846 | -42,684 | -52,195 | -191,935 | -44,583 | -45,809 | -60,667 | -52,930 | -50,853 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -140,723 | -38,846 | -42,684 | -52,195 | -191,935 | -44,583 | -45,809 | -60,667 | -52,930 | -50,853 |
基本每股稅後盈餘(元) | -6.62 | -2.13 | -2.89 | -0.18 | -0.65 | -0.17 | -0.18 | -0.24 | - | -0.20 |
稀釋每股稅後盈餘(元) | -7.68 | -2.13 | -2.89 | -0.18 | -0.72 | -0.17 | -0.18 | -0.24 | -0.20 | -0.21 |
基本平均股數(千股) | 21251.00 | 18268.00 | 14793.00 | 295098.00 | 294875.00 | 256300.00 | 255400.00 | 254252.00 | - | 251318.00 |
稀釋平均股數(千股) | 21251.00 | 18268.00 | 14793.00 | 295098.00 | 294875.00 | 256300.00 | 255400.00 | 254252.00 | - | 251318.00 |
還原基本每股稅後盈餘(元) | -6.62 | -2.13 | -2.89 | -3.60 | -13.02 | -3.48 | -3.59 | -4.80 | - | -4.00 |
還原稀釋每股稅後盈餘(元) | -7.68 | -2.13 | -2.89 | -3.60 | -14.40 | -3.40 | -3.60 | -4.80 | -4.10 | -4.20 |
還原基本平均股數(千股) | 21,251 | 18,268 | 14,793 | 14,754 | 14,743 | 12,815 | 12,770 | 12,712 | - | 12,565 |
還原稀釋平均股數(千股) | 21,251 | 18,268 | 14,793 | 14,754 | 14,743 | 12,815 | 12,770 | 12,712 | - | 12,565 |
EBITDA(千元) | -139,386 | -37,289 | -40,714 | -50,479 | -189,874 | -43,490 | -44,670 | -60,010 | -51,257 | -48,036 |